However, the study's retrospective design at a single center limits the understanding of broader patient outcomes, such as mortality or transfer rates.

This research underscores the critical importance of rapid care pathways, including same-day antiretroviral therapy initiation, in enhancing health outcomes and reducing delays in treatment.

A study conducted at a Miami clinic supports these findings, demonstrating that immediate access to HIV care leads to better health results than traditional, slower pathways.

Patients with prior HIV-related hospitalization faced longer delays before entering care under standard procedures—averaging 123 weeks—while rapid access reduced this delay to just 2.5 weeks, illustrating the benefits of immediate referral.

Long-term retention rates were similar between rapid access and standard care for patients without prior hospitalization, but those hospitalized before care had lower retention in the standard care group, at 47%, compared to rapid access.

The study analyzed 95 patients, with 64 in standard care and 31 in rapid access, using medical records from March 2016 to March 2018, with follow-up extending up to six years.

A recent study highlights that rapid access to HIV care significantly improves patient outcomes, with 96% reaching CD4 counts over 200 cells/mm3 and a median recovery time of just 87 days, compared to 277 days in standard care.

Viral load suppression was achieved in 95% of patients in the rapid access group, versus 84% in standard care, with a median time to suppression of 107 days compared to 175 days.